Anaerobic microbial DNA and cellular macromolecules

Anaerobic microbial DNA and cellular macromolecules represent the collective molecular targets for nitroimidazole antibiotics, most notably metronidazole (StatPearls, NBK539728). These targets are susceptible to damage following the intracellular reductive activation of the drug, a process that occurs specifically within anaerobic bacteria and certain protozoa (DrugBank, DB00916). The reduction is typically mediated by the pyruvate:ferredoxin oxidoreductase (PFOR) system, which transfers electrons to the nitro group of the drug, creating highly reactive nitro radical intermediates (PubChem, CID 4173). These radicals cause extensive oxidative damage to the microbial DNA, resulting in loss of helical structure, strand breakage, and the total inhibition of nucleic acid synthesis. Beyond DNA, the reactive species also target other essential cellular macromolecules such as proteins and lipids, compromising the structural and functional integrity of the microbe. This mechanism provides high therapeutic selectivity, as aerobic organisms and host cells lack the low-redox potential environment necessary for drug activation (PubMed, 10410440).

Other names

Bacterial DNAMicrobial DNAAnaerobic DNADeoxyribonucleic acid

Reductive activation by anaerobic metabolic pathways generates reactive nitro radical intermediates that cause covalent binding to and oxidative damage of DNA, leading to strand breakage and inhibition of nucleic acid synthesis (StatPearls, NBK539728).